WallStSmart
RDY

Dr. Reddy’s Laboratories Ltd ADR

NYSE: RDY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$13.73
-2.14% today

Updated 2026-04-29

Market cap
$11.46B
P/E ratio
19.07
P/S ratio
0.03x
EPS (TTM)
$0.72
Dividend yield
0.67%
52W range
$13 – $16
Volume
2.4M

Dr. Reddy’s Laboratories Ltd ADR (RDY) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$1.65B$11.83B$6.12B$4.50B$13.23B$8.01B$16.15B$13.32B$19.46B$25.03B$41.25B$21.51B$18.03B$28.70B$29.84B$35.70B$28.11B$58.87B$45.43B$46.43B
Capital expenditures$1.92B$4.75B$6.77B$4.76B$4.28B$11.61B$8.59B$7.34B$10.63B$15.33B$14.88B$40.98B$11.04B$7.49B$6.12B$12.56B$19.05B$18.86B$27.43B$34.40B
Depreciation
Stock-based comp$162.25M$175.38M$257.79M$131.00M$226.00M$265.00M$326.00M$390.00M$436.00M$498.00M$471.00M$398.00M$454.00M$389.00M$521.00M$584.00M$592.00M$397.00M$407.00M$424.00M
Free cash flow$-272.35M$7.08B$-646.96M$-256.00M$8.94B$-3.60B$7.57B$5.98B$8.84B$9.71B$26.37B$-19.47B$6.99B$21.21B$23.73B$23.14B$9.06B$40.01B$18.00B$12.03B
Investing cash flow
Financing cash flow
Dividends paid$437.48M$438.54M$737.28M$738.00M$1.23B$3.06B$2.22B$2.71B$2.98B$3.07B$4.11B$3.39B$3.99B$4.00B$3.92B$4.15B$4.15B$4.98B$6.65B$6.66B
Share repurchases
Debt repayment
Net change in cash$0.00$0.00$0.00$0.00$0.00